Français
ItalianoBond Bristol Myers Squibb 4.625% ( USU11009AT16 ) in USD
| Issuer | Bristol Myers Squibb | ||||||
| Market price | 133.63 % ▼ | ||||||
| Country |  United States
|
||||||
| ISIN code |
 USU11009AT16 ( in USD )
|
||||||
| Interest rate | 4.625% per year ( payment 2 times a year) | ||||||
| Maturity | 15/05/2044 - Bond has expired | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 976 477 000 USD | ||||||
| Cusip | U11009AT1 | ||||||
| Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) | ||||||
| Moody's rating | N/A | ||||||
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. The Bond issued by Bristol Myers Squibb ( United States ) , in USD, with the ISIN code USU11009AT16, pays a coupon of 4.625% per year. The coupons are paid 2 times per year and the Bond maturity is 15/05/2044 The Bond issued by Bristol Myers Squibb ( United States ) , in USD, with the ISIN code USU11009AT16, was rated A+ ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||